Edition:
United States

Insider Trading: Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

328.55USD
23 Oct 2017
Change (% chg)

$-9.55 (-2.82%)
Prev Close
$338.10
Open
$335.25
Day's High
$335.51
Day's Low
$327.83
Volume
1,884,888
Avg. Vol
1,351,934
52-wk High
$348.84
52-wk Low
$244.28

All Insider Trades
Trading Date Name Title Type Shares Traded Price
30 Aug 2017

Denner (Alexander J)

Director Buy 933 $316.56
31 Jul 2017

Gregory (Ginger)

Officer Buy 860 $0.00
24 Jul 2017

Alexander (Susan H)

Officer Sell 4,974 $290.01
18 Jul 2017

Alexander (Susan H)

Officer Sell 7,758 $285.00
8 Jun 2017

Posner (Brian S)

Director Sell 1,084 $256.31
6 Jun 2017

Dorsa (Caroline D)

Director Buy 1,055 $0.00
6 Jun 2017

Pangia (Robert W)

Director Buy 1,055 $0.00
6 Jun 2017

Papadopoulos (Stelios B)

Director Buy 1,740 $0.00
6 Jun 2017

Leaming (Nancy L)

Director Buy 1,055 $0.00
6 Jun 2017

Schenk (Lynn A J.D.)

Director Buy 1,055 $0.00
6 Jun 2017

Mulligan (Richard C)

Director Buy 1,055 $0.00
6 Jun 2017

Rowinsky (Eric K M.D.)

Director Buy 1,055 $0.00
6 Jun 2017

Sherwin (Stephen A)

Director Buy 1,055 $0.00
6 Jun 2017

Denner (Alexander J)

Director Buy 1,055 $0.00
6 Jun 2017

Posner (Brian S)

Director Buy 1,055 $0.00
31 May 2017

Ehlers (Michael D M.D., Ph.D.)

Officer Sell 336 $252.38
31 May 2017

Ehlers (Michael D M.D., Ph.D.)

Officer Buy 1,259 $0.00
31 May 2017

Ehlers (Michael D M.D., Ph.D.)

Officer Sell 411 $252.38
1 May 2017

Vounatsos (Michel)

Chief Executive Officer Buy 1,736 $0.00
1 May 2017

Vounatsos (Michel)

Chief Executive Officer Sell 564 $271.34
30 Apr 2017

Vounatsos (Michel)

Chief Executive Officer Buy 1,402 $271.35
26 Apr 2017

Denner (Alexander J)

Director Buy 15,000 $278.58
26 Apr 2017

Denner (Alexander J)

Director Buy 58,858 $278.48
24 Apr 2017

Clancy (Paul J.)

Chief Financial Officer Sell 9,892 $290.00
2 Apr 2017

Sandrock Alfred W Jr

Officer Sell 1,981 $274.08

Institutional Holders

% Shares Owned: 90.97%
# of Holders: 1,441
Total Shares Held: 192,336,942
3 Mo. Net Change: 193,166
# New Positions: 24
# Closed Positions: 6
# Increased Positions: 130
# Reduced Positions: 83
# Net Buyers: 47

Officers & Directors

Name Age Since Current Position

Stelios Papadopoulos

68 2014 Independent Chairman of the Board

Michel Vounatsos

55 2017 Chief Executive Officer, Director

Gregory Covino

51 2017 Interim Principal Financial Officer, Chief Accounting Officer, Vice President - Finance

Ginger Gregory

49 2017 Chief Human Resource Officer, Executive Vice President

Kenneth Di Pietro

58 2012 Executive Vice President - Human Resources

Susan Alexander

60 2011 Executive Vice President, Chief Legal Officer and Corporate Secretary

Michael Ehlers

48 2016 Executive Vice President, Head - Research and Development

Adriana Karaboutis

54 2014 Executive Vice President - Technology , Business Solutions and Corporate Affairs

Jean-Paul Kress

51 2017 Executive Vice President, President - International and Head of Global Therapeutic Operations

Paul McKenzie

51 2016 Executive Vice President - Pharmaceutical Operations & Technology

Alfred Sandrock

59 2015 Executive Vice President - Neurology Discovery and Development and Chief Medical Officer

Anirvan Ghosh

2017 Senior Vice President - Research and Early Development

Sanjay Jariwala

2017 Senior Vice President - Worldwide Medical

Camille Lee

2017 Senior Vice President - Alzheimer's Therapeutic Area

Catherine Steele

2017 Senior Vice President - Corporate Affairs

Anabella Villalobos

2017 Senior Vice President - Biotherapeutic & Medicinal Sciences (BTMS)

Alexander Denner

47 2009 Independent Director

Caroline Dorsa

57 2010 Independent Director

Nancy Leaming

69 2008 Independent Director

Richard Mulligan

62 2009 Independent Director

Robert Pangia

66 1997 Independent Director

Brian Posner

55 2008 Independent Director

Eric Rowinsky

60 2010 Independent Director

Lynn Schenk

72 1995 Independent Director

Stephen Sherwin

68 2010 Independent Director